Nvwm, LLC Novartis Ag Transaction History

Nvwm, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $9,292 - $11,379	123 New	123 $11,000
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $3,542 - $4,125	-44 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $3,524 - $3,987	44 New	44 $4,000
Q3 2021 Nov 03, 2021	SELL	$81.78 - $95.14 $4,007 - $4,661	-49 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $469,200 - $567,524	-6,010 Reduced 99.19%	49 $5,000
Q3 2020 Dec 10, 2020	BUY	$82.14 - $91.0 $39,837 - $44,135	485 Added 8.7%	6,059 $527,000
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $15,700 - $17,673	194 Added 3.61%	5,574 $487,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $19,222 - $26,930	272 Added 5.32%	5,380 $443,000
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $4,386 - $4,959	-52 Reduced 1.01%	5,108 $484,000
Q3 2019 Oct 29, 2019	BUY	$85.54 - $94.26 $426,416 - $469,886	4,985 Added 2848.57%	5,160 $448,000
Q4 2017 Mar 15, 2018	BUY	$72.33 - $77.64 $12,657 - $13,587	175	175 $15,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.